top of page

Guías y protocolos


Protocolo de manejo para la infección por COVID-19. Medicina Critica México

Acta pharmaceutica Sinica B.gif

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods  

Journal of Infection.gif

Arbidol combined with LPV/r versus LPV/r alone against Coronavirus Disease 2019: A retrospective cohort study   

Antimicrobial agents.gif

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 

Antimicrobial agents.gif

Fighting viruses with antibiotics: an overlooked path. 2016     

new insights.jpg

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?  

International Journal of Infectious Dise

Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression   

Potential inhibitors against.jpg

Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines      


Teicoplanin. An alternative drug for the treatment of COVID-19 

Use of Cloroquine in viral disease.jpg

Use of chloroquine in viral diseases. 2011  

Journal of Critical Care.gif

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19    

Antiviral research.gif

The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro 

THE LANCET Global Health.gif

Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis  

bottom of page